Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CGEMCGEM
Showing 8 of 22 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in CULLINAN THERAPEUTICS INC

CITADEL ADVISORS LLC holds 397,484 shares of CGEM (CULLINAN THERAPEUTICS INC), worth $7.2M as of 2026-Q2. The position was increased (+57.3% shares). CGEM represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$7.2M

Current Shares

397,484

Total Value Change

-$25.5M

Total Shares Change

-1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
397,484
+57.3%
$7.2M0.0%$18.21
39
2026-Q1
Increased
252,778
+129.1%
$3.6M0.0%$15.73
43
2025-Q4
Decreased
110,317
-94.4%
$1.1M0.0%$9.92
0
2025-Q3
Decreased
2M
-24.1%
$11.8M0.0%$5.97
0
2025-Q2
Decreased
2.6M
-4.9%
$19.7M0.0%$7.76
0
2025-Q1
Increased
2.7M
+2.4%
$20.8M0.0%$8.02
29
2024-Q4
Increased
2.7M
+37.2%
$32.7M0.0%$12.20
38
2024-Q3
Increased
2M
+0.6%
$32.7M0.0%$17.19
29

Other major holders of CGEM: BlackRock, Inc., BAUPOST GROUP LLC/MA, STATE STREET CORP, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used